regulatory approvals

Biotech

Moderna posts come-from-behind RSV data

A top-line readout from COVID-19 vaccine maker Moderna for a respiratory syncytial virus vaccine seems to keep pace with leading competitors.
Max Bayer Jan 17, 2023 4:55pm

Agenus withdraws cervical cancer application for balstilimab

Oct 22, 2021 8:00am

FDA stands by Aduhelm approval, use of accelerated pathway

Jul 13, 2021 3:33pm

Boston Scientific’s radioactive implant extends cancer survival

Mar 29, 2021 11:58am

Fauci: FDA will make its own decisions about COVID-19 vaccines

Aug 7, 2020 5:15am

BIO explores COVID-19's opportunities for big data, new regs

Jun 10, 2020 9:10am